Bausch & Lomb (BLCO) Retained Earnings (2021 - 2026)
Bausch & Lomb's (BLCO) quarterly Retained Earnings came in at -$1.2 billion in Q2 2026, down 2.27% YoY from -$1.2 billion in Q2 2025, and down 1.58% on a QoQ basis from -$1.2 billion in Q1 2026.
Bausch & Lomb (BLCO) Retained Earnings (2021 - 2026) Analysis & Trends
Bausch & Lomb (BLCO) has 6 years of Retained Earnings data on file, last reported at -$1.2 billion in Q2 2026.
- Quarterly Retained Earnings fell 2.27% year-over-year to -$1.2 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$1.2 billion (down 2.27% YoY) and the FY2025 annual result came in at -$1.2 billion, up 14.51% from the prior year.
- Retained Earnings declined to -$1.2 billion in Q2 2026, from -$1.2 billion in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$1.1 billion in Q1 2022 to a low of -$1.4 billion in Q3 2022.
- A 5-year average of -$1.3 billion and a median of -$1.2 billion in 2023 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings sank 13760.0% — and 2025, when it climbed 14.51%.
- Tracing BLCO's Retained Earnings over 5 years: stood at -$1.3 billion in 2022, then grew by 1.03% to -$1.2 billion in 2023, then fell by 11.24% to -$1.4 billion in 2024, then increased by 14.51% to -$1.2 billion in 2025, then decreased by 2.87% to -$1.2 billion in 2026.
- The last three Retained Earnings figures came in at -$1.2 billion (Q2 2026), -$1.2 billion (Q1 2026), and -$1.2 billion (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.93 Bn | 129.72 Bn | 1.96 Bn | 6.84 Bn |
| 2 | Becton Dickinson | 52.43 Bn | 51.56 Bn | 2.32 Bn | 17.51 Bn |
| 3 | Alcon | 35.83 Bn | 34.48 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.87 Bn | 32.40 Bn | 861.22 Mn | 7.26 Bn |
| 5 | Medline | 28.86 Bn | 26.18 Bn | 2.22 Bn | 11.40 Bn |
| 6 | West Pharmaceutical Services | 25.04 Bn | 24.60 Bn | 329.20 Mn | 4.62 Bn |
| 7 | Solventum | 15.34 Bn | 14.94 Bn | 1.29 Bn | 3.92 Bn |
| 8 | Cooper Companies | 14.89 Bn | 14.75 Bn | 735.40 Mn | 7.70 Bn |
| 9 | Baxter International | 13.65 Bn | 11.50 Bn | 1.03 Bn | 13.81 Bn |
| 10 | Bausch & Lomb | 6.17 Bn | 5.80 Bn | 867.00 Mn | -1.22 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.22 Bn |
| Mar 31, 2026 | -1.20 Bn |
| Dec 31, 2025 | -1.18 Bn |
| Sep 30, 2025 | -1.20 Bn |
| Jun 30, 2025 | -1.19 Bn |
| Mar 31, 2025 | -1.30 Bn |
| Dec 31, 2024 | -1.39 Bn |
| Sep 30, 2024 | -1.25 Bn |
| Jun 30, 2024 | -1.31 Bn |
| Mar 31, 2024 | -1.28 Bn |
| Dec 31, 2023 | -1.25 Bn |
| Sep 30, 2023 | -1.32 Bn |
| Jun 30, 2023 | -1.25 Bn |
| Mar 31, 2023 | -1.24 Bn |
| Dec 31, 2022 | -1.26 Bn |
| Sep 30, 2022 | -1.39 Bn |
| Jun 30, 2022 | -1.22 Bn |
| Mar 31, 2022 | -1.10 Bn |
| Dec 31, 2021 | -10.00 Mn |
| Sep 30, 2021 | -10.00 Mn |